WuXi AppTec | 603259

Stock Price
42.92
Daily Change
1.32 3.17%
Monthly
-7.86%
Yearly
-36.05%
Q2 Forecast
46.76
Peers Price Chg Day Year Date
1093 Cspc Pharmaceutical 6.60 0.08 1.23% -15.71% Apr/26
1177 Sino Biopharmaceutical 2.76 0.02 0.73% -35.66% Apr/26
600196 Sh Fosun Pharma 23.19 0.31 1.35% -26.89% Apr/26
600276 Jiangsu Hengrui 45.61 1.31 2.96% -5.37% Apr/26
600436 Zhangzhou Pientzehuang Pharmaceutical 225.69 5.46 2.48% -16.22% Apr/26
600518 Kangmei Pharma 2.00 0.07 3.63% -4.31% Apr/26
601607 Sh Pharmaceutical 17.85 0.04 0.22% -22.26% Apr/26

Indexes Price Day Year Date
SSE50 SHANGHAI 50 2463 30.89 1.27% -7.10% Apr/26

WuXi AppTec Co Ltd traded at 42.92 this Friday April 26th, increasing 1.32 or 3.17 percent since the previous trading session. Looking back, over the last four weeks, WuXi AppTec gained 7.86 percent. Over the last 12 months, its price fell by 36.05 percent. Looking ahead, we forecast WuXi AppTec Co Ltd to be priced at 46.76 by the end of this quarter and at 43.66 in one year, according to Trading Economics global macro models projections and analysts expectations.

WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.